Clinical Trial Update: Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing helium/oxygen (Heliox) to air/oxygen in severe COPD exacerbations has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Air/Oxygen therapy (Oxygen therapy)
• Heliox (helium-oxygen mixture)

Snippet

Sponsor: Air Liquide Santé International | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: TERMINATED